SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 105.93   -2.25 (-2.08%) Volume: 227.44k 4:00 PM EDT 18-Oct-2019
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities102/13/2019
4Statement of changes in beneficial ownership of securities102/13/2019
4Statement of changes in beneficial ownership of securities102/13/2019
4Statement of changes in beneficial ownership of securities102/13/2019
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals502/13/2019
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals502/12/2019
SC 13GStatement of acquisition of beneficial ownership by individuals102/12/2019
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/11/2019
5Annual statement of changes in beneficial ownership of securities102/07/2019
8-KCurrent report pursuant to Section 13 or 15(d)202/07/2019
8-KCurrent report pursuant to Section 13 or 15(d)202/06/2019
8-KCurrent report pursuant to Section 13 or 15(d)201/28/2019
4Statement of changes in beneficial ownership of securities101/25/2019
4Statement of changes in beneficial ownership of securities101/25/2019
4Statement of changes in beneficial ownership of securities101/25/2019
123456789101112131415